share_log
Reuters ·  Apr 25 09:00
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment